American Journal of Kidney Diseases
Volume 50, Issue 6 , Pages 1009-1019, December 2007

Relationships of N-Terminal Pro–B-Natriuretic Peptide and Cardiac Troponin T to Left Ventricular Mass and Function and Mortality in Asymptomatic Hemodialysis Patients

Indiana University School of Medicine and Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, IN.

Received 1 June 2007; accepted 27 August 2007. published online 09 November 2007.

Background

Although the cardiac biomarker troponin T (cTnT) is related strongly to mortality in patients with end-stage renal disease, the independent association of N-terminal pro–B-type natriuretic peptide (NT–pro-BNP) and cTnT levels in predicting outcomes is unknown. The objective of this study is to determine factors associated with NT–pro-BNP and cTnT and determine whether these levels are associated with mortality.

Study Design

Cohort study.

Setting & Participants

Asymptomatic hemodialysis patients (n = 150) in 4 university-affiliated hemodialysis units.

Exposure & Outcomes

For cross-sectional analysis, echocardiographic variables as exposures and NT–pro-BNP and cTnT levels as outcomes; for longitudinal analysis, association of NT–pro-BNP and cTnT levels as exposures to all-cause and cardiovascular disease mortality as outcomes.

Results

In a multivariate regression analysis, low midwall fractional shortening, a measure of poor systolic function, was an independent correlate of log NT–pro-BNP level (P < 0.01), whereas left ventricular mass index was an independent correlate of cTnT level (P < 0.01). During a median follow-up of 24 months, 46 patients died, 26 of cardiovascular causes. NT–pro-BNP levels had a strong graded relationship with all-cause (hazard ratios [HRs], 1.54, 4.78, and 4.03 for increasing quartiles; P < 0.001) and cardiovascular mortality (HRs, 2.99, 10.95, and 8.54; P < 0.01), whereas cTnT level had a weaker relationship with all-cause (HRs, 1.57, 2.32, and 3.39; P < 0.01) and cardiovascular mortality (HRs, 0.81, 2.12, and 2.14; P = 0.1). The combination of the 2 biomarker levels did not improve the association with all-cause or cardiovascular mortality compared with NT–pro-BNP level alone. NT–pro-BNP level was a marker of mortality even after adjusting for left ventricular mass index and midwall fractional shortening.

Limitations

Our cohort was predominantly black and of limited sample size.

Conclusion

NT–pro-BNP level strongly correlates with left ventricular systolic dysfunction and is associated more strongly with mortality than cTnT level in asymptomatic hemodialysis patients.

Index Words: N-Terminal pro–B-type natriuretic peptide (NT–pro-BNP), troponin T, left ventricular mass, left ventricular function, mortality, hemodialysis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Originally published online as doi:10.1053/j.ajkd.2007.08.017 on November 5, 2007.

PII: S0272-6386(07)01240-1

doi:10.1053/j.ajkd.2007.08.017

American Journal of Kidney Diseases
Volume 50, Issue 6 , Pages 1009-1019, December 2007